Lv3
238 积分 2022-07-05 加入
Global burden, trends, and attributable risk factors of women's cancers with projection to 2050: Results from the GLOBOCAN 2022 and global burden of disease study 2021
13小时前
求助中
Cervical Cancer Incidence and Mortality Trends in China: The Role of Screening
16小时前
已完结
PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer
1个月前
已完结
Exploring the next generation of antibody–drug conjugates
1个月前
已完结
Insights from a 30-year journey: function, regulation and therapeutic modulation of PD1
2个月前
已完结
Fc glycoengineering of a PD-L1 antibody harnesses Fcγ receptors for increased antitumor efficacy
2个月前
已完结
Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial
3个月前
已完结
Comparative effectiveness of immunotherapy versus lenvatinib in advanced hepatocellular carcinoma: A real-world analysis using target trial emulation
3个月前
已完结
Efficacy and Safety of Atezolizumab Plus Bevacizumab Versus Durvalumab Plus Tremelimumab for Unresectable Hepatocellular Carcinoma in Patients With Child–Pugh Class B: A Real‐World Study
3个月前
已完结
Global Stage Distribution of Breast Cancer at Diagnosis
5个月前
已完结
皖公网安备34019202002308
